Gregg, Justin R.
Zheng, Jiali
Lopez, David S.
Reichard, Chad
Browman, Gladys
Chapin, Brian
Kim, Jeri
Davis, John
Daniel, Carrie R.
Funding for this research was provided by:
Cancer Prevention and Research Institute of Texas (RP170259)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA016672)
Article History
Received: 28 July 2018
Revised: 20 December 2018
Accepted: 3 January 2019
First Online: 25 January 2019
Competing interests
: J.D. is consultant for Intuitive and received scientific funding from Janssen and GenomeDX. The other authors declare no competing interests.
: The datasets generated during and/or analysed during the current study used to support the findings of this study are not publicly available as this dataset is a resource of the University of Texas MD Anderson Cancer Centre; however, information is available from the corresponding author on reasonable request.
: This study is registered on clinical.trials.gov (trial number NCT00490763), and use of de-identified data in this study for analysis was approved as exempt by the University of Texas MD Anderson Cancer Center Institutional Review Board. Informed consent was provided by all patients in this study by virtue of completing and returning the form. The study was performed in accordance with the Declaration of Helsinki.
: This manuscript does not contain any individual person’s data in any form.
: This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0).